Skip to main content
. 2016 Sep 6;34(30):3627–3637. doi: 10.1200/JCO.2016.67.3616

Fig 3.

Fig 3.

Posttransplantation overall survival of patients with myelodysplastic syndromes classified by the revised International Prognostic Scoring System (IPSS-R) and stratified according to the presence of mutations in the ASXL1, RUNX1, and TP53 genes.